Analgesic Effect of Superficial Cervical Plexus Block in Postoperative Neck Surgeries

April 19, 2026 updated by: Mohamed Sabry Mahmoud, Sohag University

The Efficacy of Ultrasound-guided Bilateral Superficial Cervical Plexus Block on Postoperative Pain Relief in Patients Undergoing Neck Surgeries, Prospective Randomized Controlled Study.

analgesic effect of superficial cervical plexus block by using ultrasound in patients undergoing neck surgeries

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

The efficacy of ultrasound-guided bilateral superficial cervical plexus block on postoperative pain relief in patients undergoing neck surgeries, prospective randomized controlled study,To assess the analgesic efficacy of bilateral superficial cervical plexus block in reducing post-operative pain following neck surgery, decrease total opoid consumption during first 24h post operative.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Sohag, Egypt
        • Faculty of medicine, Sohag University.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • The study include all patients between 18 and 60 years of age who underwent elective neck surgery under general anesthesia

Exclusion Criteria:

  • 1. Patient refusal . 2. Patient with significant neurological , psychological disease . 3. patient known allergy to local anesthesia . 4. Patient uncorrected coagulapathy or anticoagulant therapy . 5. Patient with sever neck deformity . 6. Patient with infection at site of injection . 7. Patient with sever respiratory disease . 8. patients with regular use of analgesic medications

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group will take the block
Procedure: superficial cervical plexus block guided by ultrasound with bupivacaine
in active group we will use bupivacaine in superficial cervical plexus block to deal with pain postoperative neck surgeries
Placebo Comparator: Controlled group
Drug: Paracetamol (500 mg) tablets
controlled group will take shame block with normal saline and paracetamol only

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Analgesic effect of bilateral superficial cervical plexus block in postoperative neck surgeries
Time Frame: within the first 24 hours postoperatively
To assess the analgesic efficacy of bilateral superficial cervical plexus block on postoperative pain following neck surgery, as measured by the Visual Analog Scale Pain was assessed using the Visual Analog Scale (VAS; 0 = no pain, 10 = worst imaginable pain) at 1, 4, 8, 12, and 24 hours postoperatively.
within the first 24 hours postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total opioid consumption
Time Frame: within the first 24 hours postoperatively
To assess the total opioid consumption within the first 24 hours postoperatively and the time to first analgesic request.
within the first 24 hours postoperatively

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nausea and vomiting
Time Frame: 24 hours postoperative
incidence of postoperative nausea and vomiting
24 hours postoperative
patients satisfaction score
Time Frame: at 24 hours postoperatively
To assess patient satisfaction with postoperative pain management using a 5-point Likert scale (1 = very dissatisfied, 5 = very satisfied).
at 24 hours postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sohag University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 16, 2026

Primary Completion (Estimated)

March 30, 2027

Study Completion (Estimated)

October 30, 2027

Study Registration Dates

First Submitted

April 1, 2026

First Submitted That Met QC Criteria

April 13, 2026

First Posted (Actual)

April 20, 2026

Study Record Updates

Last Update Posted (Actual)

April 23, 2026

Last Update Submitted That Met QC Criteria

April 19, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Soh_Med_26_3_13MS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Pain

Clinical Trials on superficial cervical plexus block guided by ultrasound with bupivacaine

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe